HIV/AIDS
Research from J.A. Pineda and colleagues provide new insights into HIV/AIDS
Published in AIDS Weekly, January 28th, 2008
In this recent report, researchers in Seville, Spain conducted a study "To investigate whether concomitant antiretroviral therapy (ART) is a predictor of sustained virological response (SVR) in human immunodeficiency virus (HIV)/hepatitis C virus (HCV)-coinfected patients treated with pegylated interferon plus ribavirin. Three hundred and ten HIV/HCV-coinfected patients on pegylated interferon plus ribavirin treatment, 258 of them with concurrent ART, were included in this retrospective multicentre study."
"The predictors of SVR were evaluated. SVR was shown by 114 (37%) subjects. HCV genotype 2 or 3, plasma HCV-RNA load lower than 600 000 IU/mL, an exposure to the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2008-01-28)
More Articles from AIDS Weekly
- HIV/AIDS
HIV shifting from most to least educated in sub-Saharan Africa - HIV/AIDS
Keeping young South Africans in school: A 'social vaccine' against AIDS - HIV/AIDS
Uncovering the Achilles' heel of the HIV-1 envelope - HIV/AIDS
Research from University of California has provided new data on HIV/AIDS - HIV/AIDS
Studies from University of California, Medical Department provide new data on HIV/AIDS - HIV/AIDS Cancer
Research on HIV/AIDS cancer published by scientists at University of Nigeria - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
